AdventHealth Porter is a clinical research site located in Denver, Colorado, United States 80210.
Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.
AdventHealth Porter has participated in 132 clinical trials with 115 currently active.
Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Metastatic Esophageal Adenocarcinoma.
Sponsors: National Cancer Institute (NCI), NRG Oncology, SWOG Cancer Research Network.
Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
AdventHealth Porter has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
AdventHealth Porter has 132 clinical trials on record, with 115 currently active. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Metastatic Esophageal Adenocarcinoma.
AdventHealth Porter has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.